Medical Ethics
RSSArticles
-
Ethical Concerns if Cancer Drugs, and Science in General, are Overhyped
Half of the cancer drugs described with superlatives such as “breakthrough,” “groundbreaking” and “game-changer” were not yet approved as safe and effective, found a recent study.
-
Surprising Conflicts of Advisory Committee Speakers
Much attention has been paid to clinicians with financial ties to industry and resulting conflicts of interest, but patients who speak at public meetings also have financial ties, found a recent analysis.
-
Some Older, Chronically Ill Patients Don’t Realize They Have a Choice in Deciding Surgery
Patients and family members were surprised that postoperative recovery was so difficult, and lacked knowledge on advance directives and the fact that they could decline major surgery.
-
When IRBs Take a Walk on the Wild Side: The Dark Web
What many IRBs might not know is that researchers increasingly are turning to the “dark web” for data.
-
Sample Checklist from Tribal IRB Toolkit
The Collaborative Research Center for American Indian Health Tribal IRB Toolkit contains 101 pages, covering all aspects of initiating and running an IRB.
-
Research Institution Works With Native American Tribes to Streamline IRB Review
The Havasupai Tribe’s 1994 lawsuit against Arizona State University researchers and the institution illustrated some of the particular problems and challenges related to research involving Native American tribes.
-
AAMC Official Discusses Implications of Laws that Target Fetal Tissue Research
Research involving fetal tissue increasingly could be affected by new state regulations.
-
NIH Designates LGBT Community as Health Disparity Group
The National Institutes of Health’s recent decision to designate sexual and gender minorities as a “disparity” population for research purposes was welcomed by researchers and advocates for the LGBT community.
-
IRBs Should Ensure that Proposed Studies Include Whether Research is ‘Reproducible’
An emerging body of research reveals that past studies — some of which may form the basis of current policies and recommendations — cannot be replicated by investigators today.
-
Big Sugar’s Smoking Gun
Though the influence of industry funding on research outcomes has long been a subject of concern for IRBs, it is unusual to find a “smoking gun” strongly linking an undisclosed funding source to biased research outcomes.